Cornerstone Health Care, PA
Quick facts
Marketed products
- Combigan Two Times Daily (BID) · Ophthalmology
Combigan combines a beta-adrenergic antagonist and an alpha-2 adrenergic agonist to reduce intraocular pressure by decreasing aqueous humor production and increasing uveoscleral outflow. - Natalizumab (Tysabri) · Immunology; Neurology; Gastroenterology
Natalizumab is a monoclonal antibody that blocks the α4β1 integrin on immune cells, preventing them from crossing the blood-brain barrier and entering the central nervous system.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: